查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1946442

子宮內人工授精裝置市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、最終用戶、地區及競爭格局分類，2021-2031年）

Intrauterine Insemination, Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球子宮內人工授精（IUI）設備市場預計將從 2025 年的 4.4597 億美元成長到 2031 年的 6.6591 億美元，複合年成長率為 6.91%。

這些專用醫療設備，例如人工授精導管和精子處理試劑盒，旨在將處理過的精子直接注入子宮，以輔助自然受精。推動市場成長的關鍵因素是全球不孕症的上升，以及患者對這種治療方法的明顯偏好——與體外受精（IVF）相比，自然受孕創傷較小、成本更低。此外，已開發國家不斷擴大的保險覆蓋範圍和支持性的報銷政策也促進了市場發展，使更多人能夠獲得這些重要的不孕症治療。

市場概覽
預測期 2027-2031
市場規模：2025年 4.4597億美元
市場規模：2031年 6.6591億美元
複合年成長率：2026-2031年 6.91%
成長最快的細分市場 子宮腔內人工授精導管
最大的市場 北美洲

儘管存在這些有利條件，但與先進的輔助生殖技術相比，子宮內人工授精（IUI）的單次週期成功率較低，這給市場帶來了挑戰。這項因素可能會讓那些優先考慮即時臨床結果的患者望而卻步。然而，整個醫療保健產業對這類手術的需求依然強勁。例如，歐洲人類生殖與胚胎學會（ESHRE）在2025年發布的報告顯示，在2022年的調查期間，歐洲診所進行了超過16.8萬個子宮內人工授精治療週期，證實了人們對這類設備的持續高度依賴。

市場促進因素

全球男女不孕症的不斷上升是推動全球子宮腔內人工授精（IUI）設備市場發展的主要因素，也因此對專用導管和精子處理液的需求持續成長。隨著生理性受孕障礙的日益普遍，人們越來越依賴輔助生殖技術來克服這些問題。根據2025年12月《富比士》雜誌發表的題為「世界衛生組織在全球出生率下降之際發布生育指南」的報導，約有13.4%的15至49歲美國女性面臨不孕不育的挑戰，需要進行IUI等醫療干預。這種普遍性導致前往生育診所的患者絡繹不絕，並直接推動了用於克服子宮頸障礙、提高生育率的設備採購。

同時，生育年齡延遲和高齡生產的趨勢也是市場成長的關鍵促進因素。生物生育能力的下降使得更早的臨床介入成為必要。隨著越來越多的女性因事業或個人原因而延遲生育，自然受孕的統計難度也增加。根據英國人類受精與胚胎移植管理局（HFEA）於2024年9月發布的《生育治療趨勢與統計報告》，接受體外受精（IVF）治療的患者平均年齡將首次超過35歲，凸顯了不孕症治療患者群體的老化趨勢。這一趨勢推動了對可及的一線治療方案的需求，而經濟因素也進一步促進了這一需求。根據科菲納斯生育集團（Kofinas Fertility Group）預測，到2025年，一個典型的人工授精（IUI）週期的費用將在幾百美元到大約2000美元之間，使其成為許多夫婦經濟上可行的起點。

市場挑戰

全球子宮內人工授精（IUI）設備市場面臨一個重大障礙：與體外受精（IVF）等更先進的輔助生殖技術（ART）相比，IUI 手術的臨床成功率相對較低。這種有效性的差異常常導致患者和醫療服務提供者對繼續進行多次人工授精週期猶豫不決。由於患者渴望快速獲得確切結果，而 IUI 的初始成本優勢已不再重要，因此，越來越多的患者傾向於轉向更有效率的 ART 治療。這種轉變有效地縮短了 IUI 設備的使用時間，並減少了每位患者使用的導管和精子處理試劑盒的總數。

因此，隨著「受孕時間」在老年患者群體中變得日益重要，市場難以維持成長動能。這種性能差距已得到充分證實，並對臨床決策產生重大影響。根據歐洲人類生殖醫學會 (ESHRE) 2024 年的監測數據，體外受精 (IVF) 的臨床懷孕率約為每次胚胎移植 33.5%，明顯優於傳統上成功率較低的單週期人工授精。這一統計事實推動了對其他輔助生殖技術 (ART) 的需求，並直接限制了人工授精 (IUI) 設備產業的潛在擴張。

市場趨勢

微流體精子分選技術的引入正在革新子宮腔內人工授精（IUI）的製備方法，它取代了傳統的離心技術，後者可能導致精子細胞氧化壓力和DNA碎片化。這些微流體晶片模擬了女性生殖系統中天然存在的生理屏障，僅允許活力最強、遺傳最健康的精子穿過膜並被收集。這項技術進步對於改善IUI的臨床療效至關重要，因為樣本品質是成功的關鍵。美國國立衛生研究院於2025年7月發表的一項題為「ZyMot™微流體選裝置在標準體外受精中的臨床檢驗和應用」的研究證實了這項改進。研究發現，微流體選顯著提高了樣本以金額為準，使進行性精子的比例達到97.2%，遠高於密度梯度離心法的83.0%。

同時，家用生育監測解決方案的普及正在使周期管理去中心化，使患者能夠在臨床環境之外準確追蹤激素水平和排卵期，從而最佳化人工授精時機。這項發展減輕了患者頻繁就診進行卵泡監測的負擔，並為患者提供即時生理數據，以改善子宮腔內人工授精（IUI）流程的協調性。病患健康數據的快速累積凸顯了這項變革的規模。正如2025年12月《印度零售商》雜誌的報導“Inito完成2900萬美元B輪融資，拓展基於人工智慧的家用健康檢測”中所報道，Inito生育監測快報已處理了超過3000萬條記錄的激素數據，這表明遠距離診斷已廣泛融入現代生育治療通訊協定資金籌措。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球子宮腔內人工授精（IUI）設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（子宮腔內人工授精導管 vs. 子宮腔內人工授精培養基/精子洗滌液）
    • 按最終使用者（醫院、試管嬰兒中心/診所、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美子宮腔內人工授精（IUI）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲子宮腔內人工授精（IUI）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區子宮腔內人工授精（IUI）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲子宮內人工授精（IUI）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲子宮腔內人工授精（IUI）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球子宮腔內人工授精（IUI）設備市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Kitazato Corporation
  • Gynotec BV
  • Rocket Medical plc.
  • CooperSurgical, Inc.
  • Cook Group Inc.
  • Prince Medical SAS
  • Surgimedik Healthcare India Private Limited
  • MedGyn Products, Inc.
  • MediTech Devices Pvt. Ltd.
  • Biorad Medisys Pvt. Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12986

The Global Intrauterine Insemination (IUI) Devices Market is projected to expand from USD 445.97 Million in 2025 to USD 665.91 Million by 2031, registering a CAGR of 6.91%. These specialized medical instruments, including insemination catheters and sperm processing kits, are designed to deposit prepared sperm directly into the uterus to aid natural fertilization. Growth is primarily propelled by rising global infertility rates and a distinct patient preference for this less invasive, more affordable alternative to in vitro fertilization. Furthermore, the market is benefitting from improved insurance coverage and supportive reimbursement policies in developed nations, which serve to broaden access to these essential fertility interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 445.97 Million
Market Size 2031USD 665.91 Million
CAGR 2026-20316.91%
Fastest Growing SegmentIUI Catheters
Largest MarketNorth America

Despite these favorable conditions, the market confronts hurdles related to the lower success rates per cycle associated with IUI when compared to advanced assisted reproductive technologies, a factor that may discourage patients prioritizing immediate clinical results. Nevertheless, the demand for these procedures remains robust across the healthcare landscape. For instance, the European Society of Human Reproduction and Embryology noted in 2025 that European clinics performed more than 168,000 intrauterine insemination treatment cycles during the 2022 surveillance period, underscoring the substantial ongoing reliance on these devices.

Market Driver

Increasing rates of male and female infertility worldwide serve as a core catalyst for the Global Intrauterine Insemination (IUI) Devices Market, generating consistent demand for specialized catheters and sperm preparation media. As physiological hurdles to conception become more widespread, the reliance on assisted reproductive technologies to overcome these issues has grown. Citing a December 2025 Forbes article titled 'WHO Releases Infertility Guidelines As Global Fertility Rates Fall,' roughly 13.4% of U.S. women between the ages of 15 and 49 face infertility challenges that require medical interventions such as IUI. This extensive prevalence guarantees a steady stream of patients for fertility clinics, directly fueling the procurement of devices intended to bypass cervical barriers and improve fertilization odds.

Concurrently, the trend toward delayed parenthood and advanced maternal age plays a pivotal role in market growth, as declining biological fertility necessitates earlier clinical involvement. With more women postponing childbirth for career or personal reasons, natural conception becomes statistically more challenging. A September 2024 report by the Human Fertilisation and Embryology Authority, 'Fertility Trends & Figures Report,' revealed that the average age of patients initiating IVF has surpassed 35 years for the first time, emphasizing the aging demographic of fertility patients. This trend heightens the need for accessible first-line treatments, a demand further supported by economic factors; according to Kofinas Fertility Group in 2025, a typical IUI cycle costs between a few hundred dollars and roughly $2,000, presenting a financially feasible starting point for many couples.

Market Challenge

The Global Intrauterine Insemination (IUI) Devices Market encounters a significant obstacle due to the comparatively lower clinical success rates of IUI procedures relative to advanced assisted reproductive technologies (ART) such as in vitro fertilization (IVF). This disparity in efficacy often causes hesitation among both patients and healthcare providers regarding the pursuit of multiple insemination cycles. Because the desire for rapid, successful results frequently overrides the initial cost benefits of IUI, there is a noticeable pattern of patients accelerating their move toward high-efficacy ART treatments. This transition effectively shortens the usage window for IUI devices, thereby limiting the total volume of catheters and sperm processing kits utilized per patient.

Consequently, the market faces difficulty sustaining growth momentum as the "time-to-pregnancy" metric becomes increasingly critical for older patient demographics who might otherwise utilize IUI. This performance gap is well-documented and heavily impacts clinical decision-making. According to 2024 surveillance data from the European Society of Human Reproduction and Embryology, clinical pregnancy rates for IVF procedures reached approximately 33.5% per embryo transfer, offering a distinct advantage over the historically lower success rates of single-cycle insemination. This statistical reality steers demand toward ART alternatives, directly restricting the potential expansion of the IUI devices sector.

Market Trends

The integration of microfluidic sperm sorting technologies is fundamentally transforming the preparation stage of intrauterine insemination by superseding traditional centrifugation techniques, which can cause oxidative stress and DNA fragmentation in sperm cells. These microfluidic chips simulate the natural physiological barriers found in the female reproductive tract, permitting only the most motile and genomically sound sperm to traverse a membrane for collection. This technological advancement is vital for enhancing clinical outcomes in IUI, where sample quality is a key success factor. Validating this improvement, a July 2025 study titled 'Clinical validation and experiences of the microfluidics sperm selection device ZyMot(TM) for standard IVF,' published by the National Institutes of Health, found that microfluidic sorting yielded significantly higher sample purity, achieving a progressive motile sperm fraction of 97.2% compared to just 83.0% via density gradient centrifugation.

At the same time, the widespread adoption of home-based fertility monitoring solutions is decentralizing cycle management, enabling patients to accurately track hormone levels and ovulation windows outside of clinical settings to refine insemination timing. This development alleviates the logistical strain of frequent clinic visits for follicular monitoring and equips patients with real-time physiological data to better coordinate IUI procedures. The magnitude of this shift is highlighted by the rapid accumulation of patient health metrics; as reported by Indian Retailer in a December 2025 article, '{Funding Alert} Inito Bags $29 Mn Series B Round to Scale AI-Based At-Home Health Testing,' the Inito fertility monitor platform has processed over 30 million hormone data points, illustrating the extensive incorporation of remote diagnostics into contemporary fertility treatment protocols.

Key Market Players

  • Kitazato Corporation
  • Gynotec B.V.
  • Rocket Medical plc.
  • CooperSurgical, Inc.
  • Cook Group Inc.
  • Prince Medical SAS
  • Surgimedik Healthcare India Private Limited
  • MedGyn Products, Inc.
  • MediTech Devices Pvt. Ltd.
  • Biorad Medisys Pvt. Ltd.

Report Scope

In this report, the Global Intrauterine Insemination (IUI) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intrauterine Insemination (IUI) Devices Market, By Product

  • IUI Catheters
  • IUI Media/Sperm Wash

Intrauterine Insemination (IUI) Devices Market, By End User

  • Hospitals
  • IVF Centers & Clinics
  • Others

Intrauterine Insemination (IUI) Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intrauterine Insemination (IUI) Devices Market.

Available Customizations:

Global Intrauterine Insemination (IUI) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intrauterine Insemination (IUI) Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (IUI Catheters v/s IUI Media/Sperm Wash)
    • 5.2.2. By End User (Hospitals, IVF Centers & Clinics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Intrauterine Insemination (IUI) Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intrauterine Insemination (IUI) Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Intrauterine Insemination (IUI) Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Intrauterine Insemination (IUI) Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End User

7. Europe Intrauterine Insemination (IUI) Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intrauterine Insemination (IUI) Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End User
    • 7.3.2. France Intrauterine Insemination (IUI) Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Intrauterine Insemination (IUI) Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Intrauterine Insemination (IUI) Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Intrauterine Insemination (IUI) Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End User

8. Asia Pacific Intrauterine Insemination (IUI) Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intrauterine Insemination (IUI) Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End User
    • 8.3.2. India Intrauterine Insemination (IUI) Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Intrauterine Insemination (IUI) Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Intrauterine Insemination (IUI) Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Intrauterine Insemination (IUI) Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End User

9. Middle East & Africa Intrauterine Insemination (IUI) Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intrauterine Insemination (IUI) Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Intrauterine Insemination (IUI) Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Intrauterine Insemination (IUI) Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End User

10. South America Intrauterine Insemination (IUI) Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intrauterine Insemination (IUI) Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Intrauterine Insemination (IUI) Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Intrauterine Insemination (IUI) Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intrauterine Insemination (IUI) Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Kitazato Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Gynotec B.V.
  • 15.3. Rocket Medical plc.
  • 15.4. CooperSurgical, Inc.
  • 15.5. Cook Group Inc.
  • 15.6. Prince Medical SAS
  • 15.7. Surgimedik Healthcare India Private Limited
  • 15.8. MedGyn Products, Inc.
  • 15.9. MediTech Devices Pvt. Ltd.
  • 15.10. Biorad Medisys Pvt. Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer